Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 71567-71568 [2011-29866]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
every effort to ensure that the
membership of HHS Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Every effort is
made that a broad representation of
geographic areas, gender, ethnic and
minority groups, and the disabled are
given consideration for membership on
HHS Federal advisory committees.
Appointment to this committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of NVAC are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2011–29771 Filed 11–17–11; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC) announces the
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
following meeting of the
aforementioned committee:
Board Public Meeting Times and
Dates: (All times are Eastern Time):
8:15 a.m.–5 p.m., December 7, 2011.
8:15 a.m.–4 p.m., December 8, 2011.
Public Comment Times and Dates (All
times are Eastern Time):
5 p.m.–6:30 p.m.,* December 7, 2011.
* Please note that the public comment
periods may end before the times
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend public comment
sessions at the start times listed.
Place: Tampa Marriott Westshore,
1001 N. Westshore Blvd., Tampa,
Florida 33607; Phone: (800) 564–3489;
Fax: (813) 289–5464. Audio Conference
Call via FTS Conferencing. The USA
toll-free, dial-in number is 1–(866) 659–
0537 with a pass code of 9933701.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 150
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2013.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
71567
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Update;
Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Mound Plant Work
Group Update; Pinellas Plant Site
Profile Update; SEC petitions for:
Weldon Spring, Hooker
Electrochemical, Linde Ceramics Plant,
Feed Materials Production Center
(Fernald, Ohio), General Steel
Industries; and Savannah River Site;
SEC Petition Status Updates;
Subcommittee and Work Group Reports;
and Board Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted in accordance with the
redaction policy provided below. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her name, no attempt will be made to
redact that name. (2) NIOSH will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
E:\FR\FM\18NON1.SGM
18NON1
71568
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
Information Act and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information. (4) All disclosures of
information concerning third parties
will be redacted. (5) If it comes to the
attention of the DFO that an individual
wishes to share information with the
Board but objects to doing so in a public
forum, the DFO will work with that
individual, in accordance with the
Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
CONTACT PERSON FOR MORE INFORMATION:
Theodore Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton
Road, MS E–20, Atlanta, GA 30333,
telephone: (513) 533–6800, toll free: 1–
(800) CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: November 9, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘National HIV Behavioral Surveillance
For Young Men Who Have Sex With
Men, FOA PS11–0010201SUPP12.’’
Contact Person for More Information:
Amy Yang, Ph.D., Scientific Review
Officer, CDC, 1600 Clifton Road, NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8836.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: November 8, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–29880 Filed 11–17–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–29866 Filed 11–17–11; 8:45 am]
BILLING CODE 4163–18–P
Centers for Medicare & Medicaid
Services
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: CMS–10366]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
mstockstill on DSK4VPTVN1PROD with NOTICES
The meeting announced below
concerns National HIV Behavioral
Surveillance For Young Men Who Have
Sex With Men, Funding Opportunity
Announcement (FOA), PS11–
0010201SUPP12, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date
1 p.m.–5 p.m., January 12, 2012
(Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
AGENCY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
1. Type of Information Collection
Request: New collection (request for
new OMB control number); Title of
Information Collection: Nursing Home
Quality Improvement Questionnaire;
Use: The information obtained via the
Nursing Home Quality Improvement
Questionnaire will be utilized by CMS
staff in the Survey & Certification
Group, Division of Nursing Homes, to
identify areas for quality assurance and
performance improvement (QAPI)
technical assistance (TA) that will be
useful to nursing facilities as they
prepare to meet the new QAPI
regulation that was mandated as part of
the Affordable Care Act. Specifically,
the information collected through the
use of the questionnaire will be used to
establish a baseline of QAPI practices in
nursing homes, gather information on
the challenges and barriers to
implementing effective QAPI programs,
assess the development of QAPI
systems, determine what types of TA to
make available to nursing homes, and
assess the potential impact of TA in
advancing QAPI in nursing homes;
Form Number: CMS–10366 (OCN 0938–
New); Frequency: Once; Affected Public:
Private sector (business or other forprofits and not-for-profit institutions)
and State, Local or Tribal Governments;
Number of Respondents: 4,200; Total
Annual Responses: 4,200; Total Annual
Hours: 1,386. (For policy questions
regarding this collection contact Debra
Lyons at (410) 786–6780. For all other
issues call (410) 786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by January 17, 2012:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 76, Number 223 (Friday, November 18, 2011)]
[Notices]
[Pages 71567-71568]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-29866]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC)
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates: (All times are Eastern Time):
8:15 a.m.-5 p.m., December 7, 2011.
8:15 a.m.-4 p.m., December 8, 2011.
Public Comment Times and Dates (All times are Eastern Time):
5 p.m.-6:30 p.m.,* December 7, 2011.
* Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend public
comment sessions at the start times listed.
Place: Tampa Marriott Westshore, 1001 N. Westshore Blvd., Tampa,
Florida 33607; Phone: (800) 564-3489; Fax: (813) 289-5464. Audio
Conference Call via FTS Conferencing. The USA toll-free, dial-in number
is 1-(866) 659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2013.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor (DOL) Program
Update; Department of Energy (DOE) Program Update; Mound Plant Work
Group Update; Pinellas Plant Site Profile Update; SEC petitions for:
Weldon Spring, Hooker Electrochemical, Linde Ceramics Plant, Feed
Materials Production Center (Fernald, Ohio), General Steel Industries;
and Savannah River Site; SEC Petition Status Updates; Subcommittee and
Work Group Reports; and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted in accordance with the redaction policy provided below. Any
written comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name. (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comments; (c) A statement such as outlined in
(a) above will also appear with the agenda for a Board Meeting when it
is posted on the NIOSH Web site; (d) A statement such as in (a) above
will appear in the Federal Register Notice that announces Board and
Subcommittee meetings. (3) If an individual in making a statement
reveals personal information (e.g., medical information) about
themselves that information will not usually be redacted. The NIOSH
FOIA coordinator will, however, review such revelations in accordance
with the Freedom of
[[Page 71568]]
Information Act and the Federal Advisory Committee Act and if deemed
appropriate, will redact such information. (4) All disclosures of
information concerning third parties will be redacted. (5) If it comes
to the attention of the DFO that an individual wishes to share
information with the Board but objects to doing so in a public forum,
the DFO will work with that individual, in accordance with the Federal
Advisory Committee Act, to find a way that the Board can hear such
comments.
CONTACT PERSON FOR MORE INFORMATION: Theodore Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta, GA 30333,
telephone: (513) 533-6800, toll free: 1-(800) CDC-INFO, email:
dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: November 9, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2011-29866 Filed 11-17-11; 8:45 am]
BILLING CODE 4163-18-P
